Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Invested Capital (2016 - 2025)

Iradimed (IRMD) has disclosed Return on Invested Capital for 12 consecutive years, with 0.2% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 1.0% to 0.2% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.2%, a 1.0% decrease, with the full-year FY2024 number at 0.21%, down 1.0% from a year prior.
  • Return on Invested Capital was 0.2% for Q3 2025 at Iradimed, down from 0.2% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.22% in Q1 2024 to a low of 0.02% in Q1 2021.
  • A 5-year average of 0.17% and a median of 0.2% in 2025 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: dropped -13bps in 2021, then grew 13bps in 2022.
  • Iradimed's Return on Invested Capital stood at 0.13% in 2021, then skyrocketed by 31bps to 0.17% in 2022, then increased by 25bps to 0.22% in 2023, then dropped by -9bps to 0.2% in 2024, then dropped by 0bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Return on Invested Capital are 0.2% (Q3 2025), 0.2% (Q2 2025), and 0.2% (Q1 2025).